Provided By GlobeNewswire
Last update: Dec 5, 2024
Over Ten Medical Institutions Nationwide have Initiated RenovoCath Purchase Process, Further Accelerating Commercialization Strategy
RenovoRx Estimates Initial Target Market Size for RenovoCath of Several Hundred Million Dollars in Annual Sales
Read more at globenewswire.comNASDAQ:RNXT (7/25/2025, 8:23:07 PM)
1.27
-0.03 (-2.31%)
Find more stocks in the Stock Screener